Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-13 21:11:13

expired found date

-

created at

2024-06-11 01:03:09

updated at

2026-01-07 21:19:41

Domain name statistics

length

9

crc

9284

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

23656135

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

54614

mp size raw text

3634

mp inner links count

1

mp inner links status

20 (imported)

Open Graph

title

Geron | Working to change the course of blood cancers

description

Geron is tirelessly pursuing blood cancer treatments with the potential to extend and enhance lives.

site name

Geron

author

updated

2025-12-23 11:23:34

raw text

Working to change the course of blood cancers | Geron Skip to main content Your browser's JavaScript is disabled. To properly view the content on this page, please enable JavaScript. Research & Development Telomerase Inhibition Imetelstat Publications Clinical Trials Healthcare Professionals Patients Expanded Access Protocol Investors & Media Press Releases Events Stock Information Corporate Governance SEC Filings Analyst Coverage FAQs About Leadership Culture History Contact Careers Our ambition is to change lives by changing the course of blood cancer. We’re committed to bringing the potential power of telomerase inhibition to patients with imetelstat. See imetelstat in action Latest Updates   Research & Development Geron announces FDA acceptance of New Drug Application for imetelstat for the treatment of transfusion dependent anemia in patients with lower risk myelodysplastic syndromes (LR MDS) Learn more Research &...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2833

text words

487

text unique words

241

text lines

111

text sentences

17

text paragraphs

4

text words per sentence

28

text matched phrases

7

text matched dictionaries

4

RSS

rss status

32 (unknown)

rss found date

2024-02-25 13:20:17

rss size orig

559

rss items

0

rss spam phrases

0

rss detected language

126 (language undetectable (empty document, too short, or engines disagree))

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

138

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-02-24 07:25:29

sitemap process date

2024-12-23 10:15:26

sitemap first import date

-

sitemap last import date

-